Ellen T Kurtzman, Christine Ramdin, Lewis S Nelson
{"title":"大麻和可卡因、海洛因或甲基苯丙胺的使用以及与多种药物使用和药物治疗相关的因素在全国代表性样本中。","authors":"Ellen T Kurtzman, Christine Ramdin, Lewis S Nelson","doi":"10.1080/02791072.2025.2484389","DOIUrl":null,"url":null,"abstract":"<p><p>Cannabis is often used with other illicit drugs. Drawing from leading theories of polysubstance use, we used data from the 2009-2018 National Health and Nutrition Examination Survey to examine the prevalence of reported lifetime use of cannabis and cocaine, heroin, and/or methamphetamine among non-pregnant respondents ages 18-59 years. After identifying the subpopulation that reported using multiple drugs, we used multivariate logistic regression analysis to identify their demographic characteristics and factors associated with drug treatment participation. Within our analytic sample (<i>N</i> = 16,946), 18.7% reported lifetime cannabis use and cocaine, heroin, or methamphetamine use; 1.4% reported using all four of these drugs in their lifetime. Among individuals who reported using multiple drugs, 21.3% reported drug treatment participation. Compared to respondents who had never been in drug treatment, those who had been had higher odds of being non-Hispanic Black (AOR = 2.0, 95% CI 1.5-2.8), being in fair/poor health (AOR = 1.5, 95% CI 1.1-1.9), and reporting more medical conditions (AOR = 1.2, 95% CI 1.1-1.4). Being female, Mexican American, married, and a non-citizen lowered the odds of drug treatment. Having more than a high-school education and having a household income of more than $100,000 also reduced the odds of drug treatment.</p>","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"1-13"},"PeriodicalIF":2.1000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cannabis and Cocaine, Heroin, or Methamphetamine Use and Factors Associated with Multiple Drug Use and Drug Treatment in a Nationally Representative Sample.\",\"authors\":\"Ellen T Kurtzman, Christine Ramdin, Lewis S Nelson\",\"doi\":\"10.1080/02791072.2025.2484389\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cannabis is often used with other illicit drugs. Drawing from leading theories of polysubstance use, we used data from the 2009-2018 National Health and Nutrition Examination Survey to examine the prevalence of reported lifetime use of cannabis and cocaine, heroin, and/or methamphetamine among non-pregnant respondents ages 18-59 years. After identifying the subpopulation that reported using multiple drugs, we used multivariate logistic regression analysis to identify their demographic characteristics and factors associated with drug treatment participation. Within our analytic sample (<i>N</i> = 16,946), 18.7% reported lifetime cannabis use and cocaine, heroin, or methamphetamine use; 1.4% reported using all four of these drugs in their lifetime. Among individuals who reported using multiple drugs, 21.3% reported drug treatment participation. Compared to respondents who had never been in drug treatment, those who had been had higher odds of being non-Hispanic Black (AOR = 2.0, 95% CI 1.5-2.8), being in fair/poor health (AOR = 1.5, 95% CI 1.1-1.9), and reporting more medical conditions (AOR = 1.2, 95% CI 1.1-1.4). Being female, Mexican American, married, and a non-citizen lowered the odds of drug treatment. Having more than a high-school education and having a household income of more than $100,000 also reduced the odds of drug treatment.</p>\",\"PeriodicalId\":16902,\"journal\":{\"name\":\"Journal of psychoactive drugs\",\"volume\":\" \",\"pages\":\"1-13\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of psychoactive drugs\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/02791072.2025.2484389\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of psychoactive drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02791072.2025.2484389","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
摘要
大麻通常与其他非法药物一起使用。根据多物质使用的主要理论,我们使用了2009-2018年全国健康和营养检查调查的数据,研究了18-59岁未怀孕的受访者中报告的终身使用大麻和可卡因、海洛因和/或甲基苯丙胺的流行程度。在确定了报告使用多种药物的亚群后,我们使用多变量logistic回归分析来确定他们的人口统计学特征和与药物治疗参与相关的因素。在我们的分析样本(N = 16,946)中,18.7%的人报告终生使用大麻和可卡因、海洛因或甲基苯丙胺;1.4%的人报告在一生中使用了这四种药物。在报告使用多种药物的个人中,21.3%报告参加了药物治疗。与从未接受过药物治疗的受访者相比,接受过药物治疗的受访者是非西班牙裔黑人(AOR = 2.0, 95% CI 1.5-2.8)、健康状况一般/较差(AOR = 1.5, 95% CI 1.1-1.9)和报告更多医疗状况(AOR = 1.2, 95% CI 1.1-1.4)的几率更高。女性、墨西哥裔美国人、已婚、非公民降低了接受药物治疗的几率。高中以上学历和家庭收入超过10万美元也降低了接受药物治疗的几率。
Cannabis and Cocaine, Heroin, or Methamphetamine Use and Factors Associated with Multiple Drug Use and Drug Treatment in a Nationally Representative Sample.
Cannabis is often used with other illicit drugs. Drawing from leading theories of polysubstance use, we used data from the 2009-2018 National Health and Nutrition Examination Survey to examine the prevalence of reported lifetime use of cannabis and cocaine, heroin, and/or methamphetamine among non-pregnant respondents ages 18-59 years. After identifying the subpopulation that reported using multiple drugs, we used multivariate logistic regression analysis to identify their demographic characteristics and factors associated with drug treatment participation. Within our analytic sample (N = 16,946), 18.7% reported lifetime cannabis use and cocaine, heroin, or methamphetamine use; 1.4% reported using all four of these drugs in their lifetime. Among individuals who reported using multiple drugs, 21.3% reported drug treatment participation. Compared to respondents who had never been in drug treatment, those who had been had higher odds of being non-Hispanic Black (AOR = 2.0, 95% CI 1.5-2.8), being in fair/poor health (AOR = 1.5, 95% CI 1.1-1.9), and reporting more medical conditions (AOR = 1.2, 95% CI 1.1-1.4). Being female, Mexican American, married, and a non-citizen lowered the odds of drug treatment. Having more than a high-school education and having a household income of more than $100,000 also reduced the odds of drug treatment.